A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
Severe myocardial dysfunction and tissue damage resulting from ischemia/reperfusion (I/R) is a common clinical scenario in patients with certain types of heart diseases and therapies such as thrombolysis, percutaneous coronary intervention, coronary artery bypass grafting, and cardiac transplantatio...
Main Authors: | Buxing Chen, Fenghe Du, Hongxia Wang, Juanjuan Song, Xiaowei Xu, Min Zhang, Caixia Guo, Xiangjun Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/13/9/11923 |
Similar Items
-
Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia
by: Busra Ozkan, et al.
Published: (2024-01-01) -
Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years
by: Julie Magnier, et al.
Published: (2022-06-01) -
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis
by: Isabella M. Atzeni, et al.
Published: (2023-06-01) -
P.39 The Role of Advanced Glycation End Products in Vascular Ageing. Which Parameter is the Most Suitable as Biomarker?
by: Otto Mayer, et al.
Published: (2020-12-01) -
Concentrations of N<sup>6</sup>-Carboxymethyllysine (CML), N<sup>6</sup>-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2022-12-01)